Buckingham et al., 2014 - Google Patents
Autophagy and the effects of its inhibition on varicella-zoster virus glycoprotein biosynthesis and infectivityBuckingham et al., 2014
View PDF- Document ID
- 9921331275868776742
- Author
- Buckingham E
- Carpenter J
- Jackson W
- Grose C
- Publication year
- Publication venue
- Journal of virology
External Links
Snippet
Autophagy and the effects of its inhibition or induction were investigated during the entire infectious cycle of varicella-zoster virus (VZV), a human herpesvirus. As a baseline, we first enumerated the number of autophagosomes per cell after VZV infection compared with the …
- 241000701085 Human alphaherpesvirus 3 0 title abstract description 103
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Buckingham et al. | Autophagy and the effects of its inhibition on varicella-zoster virus glycoprotein biosynthesis and infectivity | |
Belzile et al. | Trehalose, an mTOR-independent inducer of autophagy, inhibits human cytomegalovirus infection in multiple cell types | |
Chaumorcel et al. | The human cytomegalovirus protein TRS1 inhibits autophagy via its interaction with Beclin 1 | |
Taisne et al. | Human cytomegalovirus hijacks the autophagic machinery and LC3 homologs in order to optimize cytoplasmic envelopment of mature infectious particles | |
McFarlane et al. | Early induction of autophagy in human fibroblasts after infection with human cytomegalovirus or herpes simplex virus 1 | |
Takahashi et al. | Varicella-zoster virus infection induces autophagy in both cultured cells and human skin vesicles | |
Nicola et al. | Cellular and viral requirements for rapid endocytic entry of herpes simplex virus | |
Akula et al. | Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis | |
Hetzenecker et al. | HCMV induces macropinocytosis for host cell entry in fibroblasts | |
Li et al. | Cell surface THY-1 contributes to human cytomegalovirus entry via a macropinocytosis-like process | |
Lussignol et al. | The herpes simplex virus 1 Us11 protein inhibits autophagy through its interaction with the protein kinase PKR | |
Calistri et al. | Intracellular trafficking and maturation of herpes simplex virus type 1 gB and virus egress require functional biogenesis of multivesicular bodies | |
Vanarsdall et al. | PDGF receptor-α does not promote HCMV entry into epithelial and endothelial cells but increased quantities stimulate entry by an abnormal pathway | |
Feire et al. | The glycoprotein B disintegrin-like domain binds beta 1 integrin to mediate cytomegalovirus entry | |
Devadas et al. | Herpes simplex virus internalization into epithelial cells requires Na+/H+ exchangers and p21-activated kinases but neither clathrin-nor caveolin-mediated endocytosis | |
Roller et al. | The herpes simplex virus 1 UL51 gene product has cell type-specific functions in cell-to-cell spread | |
Cheng et al. | African swine fever virus L83L negatively regulates the cGAS-STING-mediated IFN-I pathway by recruiting tollip to promote STING autophagic degradation | |
Kalu et al. | Nelfinavir inhibits maturation and export of herpes simplex virus 1 | |
Bahnamiri et al. | Mechanism of nuclear lamina disruption and the role of pUS3 in herpes simplex virus 1 nuclear egress | |
Wudiri et al. | Cellular cholesterol facilitates the postentry replication cycle of herpes simplex virus 1 | |
Cappadona et al. | Human cytomegalovirus pUL47 modulates tegumentation and capsid accumulation at the viral assembly complex | |
Rebmann et al. | Phosphorylation of Golgi peripheral membrane protein Grasp65 is an integral step in the formation of the human cytomegalovirus cytoplasmic assembly compartment | |
Huber et al. | Herpes simplex virus with highly reduced gD levels can efficiently enter and spread between human keratinocytes | |
Yin et al. | Autophagy activated by duck enteritis virus infection positively affects its replication | |
Siracusano et al. | Early activation of MyD88-mediated autophagy sustains HSV-1 replication in human monocytic THP-1 cells |